leisure time -WSS

leisure time

author：leisure time 2025-10-01 12:35:39 - browse：73997

The 7 a.m. Acela out of South Station in Boston trembled along the rails toward Manhattan. David Sabatini sat alone on the left side of the train. He had brought along a science paper to work on, but had a lot on his mind. He kept his Wordle streak alive on his phone, and stared out at the picturesque Connecticut coastline. His clothing hung loose from recent weight loss, presumably from stress.

It was Jan. 4, 2022, a brisk sunny day. The tall, gangling scientist with a long mess of black hair had once generated Nobel Prize buzz for his discoveries in biology. But at that moment, he was unemployed in his 50s, his reputation ruined, spending many nights in his brother’s guest room or on his ex-wife’s sofa, so emotionally distraught that his family was afraid to leave him alone.

Sabatini was journeying to New York in search of a new beginning, an against-all-odds comeback.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Why psychiatrists like me stop taking insurance

WSS

Morgan Health, with ambitious aims, wants you to know it’s still here

New weight loss drugs work. But how can they best be used?

Gut bacteria may contribute to kidney autoimmunity, study finds

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Oral obesity drug from Viking Therapeutics hits key early target

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

knowledge

leisure time

Wikipedia

Affirmative action in medical school literally saved lives

Bird flu in dairy cattle: New measures to control spread to humans

Hepatitis C has a cure — but many Americans still lack access to it

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Wildfire smoke exposes gaps in outdoor worker protections

GSK Flovent asthma inhalers replaced by authorized generics

Sports medicine is finally prioritizing gender equality

Oral obesity drug from Viking Therapeutics hits key early target

Trump demands the U.S. pay no more for drugs than other countries … again

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

focus

Burning questions for the 2024 JPM Healthcare Conference

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Insurer loopholes limit power of law against surprise medical bills

Study: Black kids more likely to die after surgery than white kids

Chronically ill young patients struggle to find fertility info

U.K. sequencing study surfaces new findings about tumor DNA

leisure time

entertainment

entertainment

focus